Literature DB >> 6620015

Brain metastases in children.

F Graus, R W Walker, J C Allen.   

Abstract

We reviewed the records of 31 children under the age of 21 years with parenchymal brain metastases diagnosed by CT scan (13 patients) or necropsy (18). Brain metastases were found in 18 of 139 (13%) children with solid tumors in whom complete postmortem examinations were done. Osteogenic sarcoma and rhabdomyosarcoma were the most frequent primary tumors causing brain metastases in patients younger than 15 years, and testicular germ cell tumor, from age 15 to 21 years. Evidence of intratumoral hemorrhage was found in 50% of autopsy cases. Pulmonary metastases were present in 28 of 31 (90%). The median interval from recognition of pulmonary metastases to the development of brain metastases was 10 months. No patient had evidence of brain metastases at diagnosis of the systemic cancer. In only one patient was the brain the only site of relapse. Following detection of brain metastases, the median survival was seven months in six patients who underwent surgery and whole-brain radiation therapy and four months in 15 given radiotherapy (3000 rads) alone. Patients with relatively radioresistant brain metastases may benefit from surgical excision or higher doses of radiation, or both.

Entities:  

Mesh:

Year:  1983        PMID: 6620015     DOI: 10.1016/s0022-3476(83)80583-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

Review 1.  Brain metastasis in pediatric extracranial solid tumors: survey and literature review.

Authors:  Rejin Kebudi; Inci Ayan; Omer Görgün; Fulya Yaman Ağaoğlu; Sema Vural; Emin Darendeliler
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

2.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

Review 3.  Current management of metastatic brain disease.

Authors:  Tulika Ranjan; Lauren E Abrey
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

4.  Computed tomography in intracranial, supratentorial metastases in children.

Authors:  H Pedersen; J McConnell; D C Harwood-Nash; C R Fitz; S H Chuang
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

5.  Wilms' tumor with intracranial metastases presenting with intracranial hemorrhage.

Authors:  Y Takamiya; S Toya; M Otani; H Inoue; S Okui; N Takenaka
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

6.  Central Nervous System Involvement of Rhabdomyosarcoma: A Single Institution Experience.

Authors:  Daniel C Moreira; Margaret E Macy; Carrye R Cost; Brian S Greffe; Timothy P Garrington
Journal:  J Pediatr Hematol Oncol       Date:  2019-03       Impact factor: 1.289

7.  Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

Authors:  Christos Christodoulou; Anna Kalogera-Fountzila; Vasilios Karavasilis; George Kouvatseas; Christos N Papandreou; Epaminontas Samantas; Kalliopi Varaki; Georgios Papadopoulos; Mattheos Bobos; Grigorios Rallis; Evangelia Razis; Athina Goudopoulou; Konstantine T Kalogeras; Konstantinos N Syrigos; George Fountzilas
Journal:  J Neurooncol       Date:  2017-07-07       Impact factor: 4.130

8.  Diapeutic cancer-targeting alkylphosphocholine analogs may advance management of brain malignancies.

Authors:  Ray R Zhang; Kyle I Swanson; Lance T Hall; Jamey P Weichert; John S Kuo
Journal:  CNS Oncol       Date:  2016-09-12

Review 9.  Brain metastases.

Authors:  P Y Wen; J S Loeffler
Journal:  Curr Treat Options Oncol       Date:  2000-12

10.  Resection of brain metastases from sarcoma.

Authors:  M Wroński; E Arbit; M Burt; G Perino; J H Galicich; M F Brennan
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.